With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

After 6 months, placebo was associated with a mean weight gain of 0.4 kg (o.88 lb), compared with 1.2-1.9 kg (2.6-4.2 lb) ...

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...

With a late-stage trial win for its Norditropin heir in hand, Novo Nordisk is making good on plans to boost its profile in ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

Singapore is negotiating with the U.S. to ease tariffs on pharmaceuticals and secure access to advanced chips amid shifting ...

Older patients with Crohn’s disease are at elevated risk for recurrence following ileocolic resection but less frequently ...

The order calls on the health department, led by Robert F. Kennedy Jr., to broker new price tags for drugs over the next ...

Pfizer Inc. (PFE) is currently at $23.04, up $0.77 or 3.43% --On pace for largest percent increase since Dec. 17, 2024, when it rose 4.67% --Down 62.38% from its all-time closing high of $61.25 on Dec ...